| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000013023 |
| Receipt No. | R000015202 |
| Official scientific title of the study | Effects of monounsaturated fatty acid and sitagliptin on insulin secretion and endothelial function (EMSIE study) |
| Date of disclosure of the study information | 2014/02/14 |
| Last modified on | 2018/08/13 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Effects of monounsaturated fatty acid and sitagliptin on insulin secretion and endothelial function (EMSIE study) | |
| Title of the study (Brief title) | EMSIE study | |
| Region |
|
|
| Condition | ||
| Condition | Healthy volunteer and patients with type 2 diabetes mellitus | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To study effects of monounsaturated fatty acid and sitagliptin on insulin secretory profiles and endothelial function in healthy volunteer and in patients with type 2 diabetes mellitus |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Blood pressure, glucose, insulin, lipids, GIP, GLP-1, adipocytokines and %change of flow- and nitroglycerine-mediated dilatation before and after meal tolerance test |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is considered as a block. |
| Blocking | YES |
| Concealment | Pseudo-randomization |
| Intervention | |||
| No. of arms | 4 | ||
| Purpose of intervention | Prevention | ||
| Type of intervention |
|
||
| Interventions/Control_1 | carbohydrate 75 g (300kcal) | ||
| Interventions/Control_2 | carbohydrate 75 g (300kcal) + butter (240kcal) | ||
| Interventions/Control_3 | carbohydrate 75 g (300kcal) + oliveoil 27 g (240kcal) | ||
| Interventions/Control_4 | carbohydrate 75 g (300kcal) + sitagliptin 50mg | ||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | Healthy volunteer and type 2 diabetes mellitus, who agree to the study protocol | |||
| Key exclusion criteria | 1. Medication affecting study results
2. Poor diabetes control 3. Severe infection, operation and trauma before 3 months 4. Severe liver or kidney dysfunction 5. Other inappropriate causes |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Michio Shimabukuro |
| Organization | The University of Tokushima Graduate School of Health Biosciences |
| Division name | Department of Cardio-Diabetes Medicine |
| Address | 3-18-15 Kuramoto, Tokushima 770-8503, Japan |
| TEL | 080-633-7859 |
| mshimabukuro-ur@umin.ac.jp | |
| Public contact | |
| Name of contact person | Michio Shimabukuro |
| Organization | The University of Tokushima Graduate School of Health Biosciences |
| Division name | Department of Cardio-Diabetes Medicine |
| Address | 3-18-15 Kuramoto, Tokushima 770-8503, Japan |
| TEL | 080-633-7859 |
| Homepage URL | |
| mshimabukuro-ur@umin.ac.jp | |
| Sponsor | |
| Institute | Department of Cardio-Diabetes Medicine, The University of Tokushima Graduate School of Health Biosciences |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Cardio-Diabetes Medicine, The University of Tokushima Graduate School of Health Biosciences |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000015202 |